NAD+ Injection
Injectable NAD+ formulation for direct intravenous or intramuscular administration. Each 50mg vial is manufactured under aseptic conditions in cGMP-certified facilities. Designed for clinical protocols where maximum bioavailability and precise dosage control are critical.
Request a Quote
Pricing available for qualified medical professionals, clinics, and distributors.
Enquire NowDownload MonographView FAQMechanism of Action
Injectable NAD+ bypasses gastrointestinal degradation and first-pass hepatic metabolism, delivering the coenzyme directly to the bloodstream at near-100% bioavailability. Once in systemic circulation, NAD+ is taken up by cells to support mitochondrial energy production (oxidative phosphorylation), activate sirtuins for DNA repair and metabolic regulation, and replenish the depleted NAD+ pool associated with aging.
Read the researchClinical Benefits
- Direct NAD+ delivery to bloodstream
- No gastrointestinal degradation
- 80% reported improvement in energy levels in clinical observations
- Precise dosage administration
Specifications
Storage & Handling
- Store unreconstituted vials at 2–8°C
- Protect from light
- Reconstituted solution: use immediately or within 24 hours if refrigerated
- Do not freeze reconstituted solution
Reconstitution
Reconstitute with the diluent provided or sterile saline per clinical protocol. Solution should be clear and colourless. For IV use, dilute further in appropriate IV fluid as per clinical guidelines.
For professional medical use only. Not for retail sale to the general public. Pricing available on request for qualified medical institutions and distributors.